Literature DB >> 16456091

Molecular signatures determining coronary artery and saphenous vein smooth muscle cell phenotypes: distinct responses to stimuli.

David Xing-Fei Deng1, Joshua M Spin, Anya Tsalenko, Aditya Vailaya, Amir Ben-Dor, Zohar Yakhini, Phil Tsao, Laurakay Bruhn, Thomas Quertermous.   

Abstract

OBJECTIVE: Phenotypic differences between vascular smooth muscle cell (VSMC) subtypes lead to diverse pathological processes including atherosclerosis, postangioplasty restenosis and vein graft disease. To better understand the molecular mechanisms underlying functional differences among distinct SMC subtypes, we compared gene expression profiles and functional responses to oxidized low-density lipoprotein (OxLDL) and platelet-derived growth factor (PDGF) between cultured SMCs from human coronary artery (CASM) and saphenous vein (SVSM). METHODS AND
RESULTS: OxLDL and PDGF elicited markedly different functional responses and expression profiles between the 2 SMC subtypes. In CASM, OxLDL inhibited cell proliferation and migration and modified gene expression of chemokines (CXCL10, CXCL11 and CXCL12), proinflammatory cytokines (IL-1, IL-6, and IL-18), insulin-like growth factor binding proteins (IGFBPs), and both endothelial and smooth muscle marker genes. In SVSM, OxLDL promoted proliferation partially via IGF1 signaling, activated NF-kappaB and phosphatidylinositol signaling pathways, and upregulated prostaglandin (PG) receptors and synthases. In untreated cells, alpha-chemokines, proinflammatory cytokines, and genes associated with apoptosis, inflammation, and lipid biosynthesis were higher in CASM, whereas some beta-chemokines, metalloproteinase inhibitors, and IGFBPs were higher in SVSM. Interestingly, the basal expression levels of these genes seemed closely related to their responses to OxLDL and PDGF. In summary, our results suggest dramatic differences in gene expression patterns and functional responses to OxLDL and PDGF between venous and arterial SMCs, with venous SMCs having stronger proliferative/migratory responses to stimuli but also higher expression of atheroprotective genes at baseline.
CONCLUSIONS: These results reveal molecular signatures that define the distinct phenotypes characteristics of coronary artery and saphenous vein SMC subtypes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16456091     DOI: 10.1161/01.ATV.0000208185.16371.97

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  29 in total

1.  A multi-gene transcriptional profiling approach to the discovery of cell signature markers.

Authors:  Youichiro Wada; Dan Li; Anne Merley; Andrew Zukauskas; William C Aird; Harold F Dvorak; Shou-Ching Shih
Journal:  Cytotechnology       Date:  2010-10-23       Impact factor: 2.058

Review 2.  Vascular Smooth Muscle as a Target for Novel Therapeutics.

Authors:  Karen E Porter; Kirsten Riches
Journal:  Curr Diab Rep       Date:  2015-10       Impact factor: 4.810

Review 3.  Matrix Metalloproteinases as Regulators of Vein Structure and Function: Implications in Chronic Venous Disease.

Authors:  Elisabeth MacColl; Raouf A Khalil
Journal:  J Pharmacol Exp Ther       Date:  2015-08-28       Impact factor: 4.030

Review 4.  Matrix Metalloproteinases, Vascular Remodeling, and Vascular Disease.

Authors:  Xi Wang; Raouf A Khalil
Journal:  Adv Pharmacol       Date:  2017-09-19

5.  Inhibition of smooth muscle cell migration and neointima formation in vein grafts by overexpression of matrix metalloproteinase-3.

Authors:  Klaus Kallenbach; Rolf Salcher; Albert Heim; Matthias Karck; Paolo Mignatti; Axel Haverich
Journal:  J Vasc Surg       Date:  2009-03       Impact factor: 4.268

6.  Insulin-like growth factor-1 induces phosphorylation of PI3K-Akt/PKB to potentiate proliferation of smooth muscle cells in human saphenous vein.

Authors:  Guanghong Jia; Amit K Mitra; Deepak M Gangahar; Devendra K Agrawal
Journal:  Exp Mol Pathol       Date:  2010-05-13       Impact factor: 3.362

Review 7.  Matrix Metalloproteinase Inhibitors as Investigational and Therapeutic Tools in Unrestrained Tissue Remodeling and Pathological Disorders.

Authors:  Jie Liu; Raouf A Khalil
Journal:  Prog Mol Biol Transl Sci       Date:  2017-05-10       Impact factor: 3.622

8.  Endothelial long non-coding RNAs regulated by oxidized LDL.

Authors:  Krishna K Singh; Pratiek N Matkar; Yi Pan; Adrian Quan; Vijay Gupta; Hwee Teoh; Mohammed Al-Omran; Subodh Verma
Journal:  Mol Cell Biochem       Date:  2017-03-18       Impact factor: 3.396

9.  Differential expression of pancreatitis-associated protein and thrombospondins in arterial versus venous tissues.

Authors:  Theodora Szasz; Susan Eddy; Joseph Paulauskis; Robert Burnett; Merete Ellekilde; Juan L Iovanna; Stephanie W Watts
Journal:  J Vasc Res       Date:  2009-06-30       Impact factor: 1.934

10.  Gene expression profiling demonstrates a novel role for foetal fibrocytes and the umbilical vessels in human fetoplacental development.

Authors:  Jung-Sun Kim; Roberto Romero; Adi Laurentiu Tarca; Christopher LaJeunesse; Yu Mi Han; Mi Jeong Kim; Yeon Lim Suh; Sorin Draghici; Pooja Mittal; Francesca Gotsch; Juan Pedro Kusanovic; Sonia Hassan; Chong Jai Kim
Journal:  J Cell Mol Med       Date:  2008-02-24       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.